Utah Medical Products, Inc. (UTMD)
USD 62.0
(-0.85%)
USD 62.0
(-0.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 24.8 Million USD | 25.34% |
| 2022 | 26.87 Million USD | -35.99% |
| 2021 | 26.16 Million USD | 125.54% |
| 2020 | 20.91 Million USD | -22.26% |
| 2019 | 24.51 Million USD | 194.31% |
| 2018 | 21.65 Million USD | -185.62% |
| 2017 | 21.78 Million USD | -7.82% |
| 2016 | 19.02 Million USD | -2.05% |
| 2015 | 18.83 Million USD | -3.19% |
| 2014 | 19.63 Million USD | 68.49% |
| 2013 | 18.1 Million USD | -2.31% |
| 2012 | 18.45 Million USD | 28.18% |
| 2011 | 14.71 Million USD | -52.86% |
| 2010 | 9.67 Million USD | -3.07% |
| 2009 | 10.21 Million USD | 136.96% |
| 2008 | 11.56 Million USD | 1.24% |
| 2007 | 11.35 Million USD | 2.94% |
| 2006 | 11.46 Million USD | 12.55% |
| 2005 | 9.91 Million USD | -9.98% |
| 2004 | 16.12 Million USD | -7.6% |
| 2003 | 11.7 Million USD | -0.18% |
| 2002 | 11.71 Million USD | 5.47% |
| 2001 | 11.21 Million USD | 5.97% |
| 2000 | 10.55 Million USD | 1.0% |
| 1999 | 10.47 Million USD | 30.91% |
| 1998 | 8.8 Million USD | 38.18% |
| 1997 | 6.97 Million USD | -52.17% |
| 1996 | 13.3 Million USD | -5.74% |
| 1995 | 13.4 Million USD | 17.31% |
| 1994 | 11.3 Million USD | 26.83% |
| 1993 | 9.9 Million USD | -10.87% |
| 1992 | 10.3 Million USD | 12.2% |
| 1991 | 8.6 Million USD | 32.31% |
| 1990 | 6.5 Million USD | 47.73% |
| 1989 | 4.4 Million USD | 69.23% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 4.9 Million USD | 18.76% |
| 2024 Q2 | 4.11 Million USD | -37.27% |
| 2024 Q1 | 5.46 Million USD | 9.97% |
| 2023 Q2 | 4.42 Million USD | -0.32% |
| 2023 FY | - USD | 25.34% |
| 2023 Q3 | 3.96 Million USD | -10.31% |
| 2023 Q4 | 4.97 Million USD | 25.22% |
| 2023 Q1 | 4.43 Million USD | -12.45% |
| 2022 FY | - USD | -35.99% |
| 2022 Q1 | 7.53 Million USD | -7.15% |
| 2022 Q4 | 5.07 Million USD | -1.38% |
| 2022 Q2 | 5.05 Million USD | -32.86% |
| 2022 Q3 | 5.14 Million USD | 1.66% |
| 2021 Q1 | 3.88 Million USD | -9.18% |
| 2021 FY | - USD | 125.54% |
| 2021 Q4 | 8.11 Million USD | 59.12% |
| 2021 Q3 | 5.09 Million USD | 6.99% |
| 2021 Q2 | 4.76 Million USD | 22.59% |
| 2020 FY | - USD | -22.26% |
| 2020 Q1 | 3.86 Million USD | -17.44% |
| 2020 Q3 | 3.58 Million USD | 81.49% |
| 2020 Q4 | 4.28 Million USD | 19.29% |
| 2020 Q2 | 1.97 Million USD | -48.82% |
| 2019 Q4 | 4.67 Million USD | 7.05% |
| 2019 Q1 | 4.1 Million USD | 196.09% |
| 2019 FY | - USD | 194.31% |
| 2019 Q2 | 4.48 Million USD | 9.24% |
| 2019 Q3 | 4.37 Million USD | -2.45% |
| 2018 FY | - USD | -185.62% |
| 2018 Q1 | 4.97 Million USD | -7.26% |
| 2018 Q3 | 5.11 Million USD | -11.88% |
| 2018 Q4 | -4.26 Million USD | -183.4% |
| 2018 Q2 | 5.8 Million USD | 16.86% |
| 2017 Q4 | 5.36 Million USD | -17.49% |
| 2017 Q2 | 6.89 Million USD | 45.88% |
| 2017 FY | - USD | -7.82% |
| 2017 Q1 | 4.72 Million USD | -13.14% |
| 2017 Q3 | 6.49 Million USD | -5.76% |
| 2016 FY | - USD | -2.05% |
| 2016 Q1 | 5.05 Million USD | -14.27% |
| 2016 Q2 | 5.05 Million USD | -0.04% |
| 2016 Q3 | 5.77 Million USD | 14.33% |
| 2016 Q4 | 5.44 Million USD | -5.8% |
| 2015 Q3 | 4 Million USD | -15.82% |
| 2015 FY | - USD | -3.19% |
| 2015 Q2 | 4.75 Million USD | 22.57% |
| 2015 Q1 | 3.87 Million USD | -39.31% |
| 2015 Q4 | 5.89 Million USD | 47.35% |
| 2014 Q2 | 6.34 Million USD | 4.94% |
| 2014 Q4 | 6.38 Million USD | 3.1% |
| 2014 FY | - USD | 68.49% |
| 2014 Q3 | 6.19 Million USD | -2.41% |
| 2014 Q1 | 6.05 Million USD | 69.99% |
| 2013 Q1 | 6.28 Million USD | 58.77% |
| 2013 FY | - USD | -2.31% |
| 2013 Q2 | 3.71 Million USD | -40.85% |
| 2013 Q3 | 5.94 Million USD | 60.13% |
| 2013 Q4 | 3.55 Million USD | -40.17% |
| 2012 Q1 | 5.11 Million USD | 60.84% |
| 2012 FY | - USD | 28.18% |
| 2012 Q3 | 3.96 Million USD | 7.78% |
| 2012 Q2 | 3.67 Million USD | -28.14% |
| 2012 Q4 | 3.95 Million USD | -0.1% |
| 2011 Q1 | 2.15 Million USD | -12.06% |
| 2011 Q4 | 3.17 Million USD | -10.17% |
| 2011 Q2 | 3.23 Million USD | 49.81% |
| 2011 Q3 | 3.53 Million USD | 9.46% |
| 2011 FY | - USD | -52.86% |
| 2010 FY | - USD | -3.07% |
| 2010 Q4 | 2.45 Million USD | 10.29% |
| 2010 Q3 | 2.22 Million USD | -4.38% |
| 2010 Q2 | 2.32 Million USD | 2.51% |
| 2010 Q1 | 2.27 Million USD | -21.34% |
| 2009 Q4 | 2.88 Million USD | 21.06% |
| 2009 FY | - USD | 136.96% |
| 2009 Q3 | 2.38 Million USD | -62.19% |
| 2009 Q2 | 6.3 Million USD | 143.15% |
| 2009 Q1 | 2.59 Million USD | 4.05% |
| 2008 Q1 | 2.48 Million USD | -22.61% |
| 2008 Q3 | 3.3 Million USD | 24.17% |
| 2008 Q4 | 2.49 Million USD | -24.55% |
| 2008 FY | - USD | 1.24% |
| 2008 Q2 | 2.66 Million USD | 7.04% |
| 2007 FY | - USD | 2.94% |
| 2007 Q4 | 3.21 Million USD | 28.59% |
| 2007 Q3 | 2.49 Million USD | -2.23% |
| 2007 Q2 | 2.55 Million USD | 0.47% |
| 2007 Q1 | 2.54 Million USD | -20.01% |
| 2006 FY | - USD | 12.55% |
| 2006 Q1 | 2.37 Million USD | -1.86% |
| 2006 Q2 | 2.31 Million USD | -2.61% |
| 2006 Q4 | 3.17 Million USD | 20.84% |
| 2006 Q3 | 2.63 Million USD | 13.75% |
| 2005 FY | - USD | -9.98% |
| 2005 Q4 | 2.41 Million USD | 20.95% |
| 2005 Q3 | 2 Million USD | -17.66% |
| 2005 Q2 | 2.42 Million USD | -1.9% |
| 2005 Q1 | 2.47 Million USD | 1.31% |
| 2004 Q2 | 2.65 Million USD | -2.07% |
| 2004 Q3 | 2.55 Million USD | -3.43% |
| 2004 Q4 | 2.44 Million USD | -4.49% |
| 2004 FY | - USD | -7.6% |
| 2004 Q1 | 2.7 Million USD | 3.48% |
| 2003 Q2 | 2.96 Million USD | -0.48% |
| 2003 Q4 | 2.83 Million USD | -7.56% |
| 2003 FY | - USD | -0.18% |
| 2003 Q1 | 2.97 Million USD | 3.96% |
| 2003 Q3 | 2.93 Million USD | -1.63% |
| 2002 FY | - USD | 5.47% |
| 2002 Q1 | 2.83 Million USD | -41.51% |
| 2002 Q2 | 2.91 Million USD | 2.57% |
| 2002 Q3 | 3.05 Million USD | 5.49% |
| 2002 Q4 | 2.91 Million USD | -5.51% |
| 2001 Q2 | 2.84 Million USD | 2.43% |
| 2001 Q3 | 2.86 Million USD | -1.03% |
| 2001 Q4 | 5.13 Million USD | 66.63% |
| 2001 FY | - USD | 5.97% |
| 2001 Q1 | 2.72 Million USD | 17.36% |
| 2000 Q2 | 2.68 Million USD | 9.83% |
| 2000 Q3 | 2.69 Million USD | -0.23% |
| 2000 Q4 | 2.73 Million USD | -11.24% |
| 2000 Q1 | 2.44 Million USD | -8.98% |
| 2000 FY | - USD | 1.0% |
| 1999 Q2 | 2.5 Million USD | 9.09% |
| 1999 Q3 | 2.8 Million USD | 12.5% |
| 1999 Q4 | 2.87 Million USD | -1.89% |
| 1999 Q1 | 2.3 Million USD | 0.0% |
| 1999 FY | - USD | 30.91% |
| 1998 Q4 | 2.6 Million USD | 0.0% |
| 1998 FY | - USD | 38.18% |
| 1998 Q1 | 1.9 Million USD | 0.0% |
| 1998 Q2 | 2 Million USD | 28.57% |
| 1998 Q3 | 2.4 Million USD | 22.22% |
| 1997 Q2 | 1.4 Million USD | 22.22% |
| 1997 Q4 | 2 Million USD | -33.33% |
| 1997 Q3 | 2.2 Million USD | 90.91% |
| 1997 FY | - USD | -52.17% |
| 1997 Q1 | 1.4 Million USD | -70.97% |
| 1996 FY | - USD | -5.74% |
| 1996 Q4 | 3.3 Million USD | -6.06% |
| 1996 Q3 | 3.6 Million USD | 0.0% |
| 1996 Q2 | 3.5 Million USD | 65.0% |
| 1996 Q1 | 3.1 Million USD | -37.5% |
| 1995 Q1 | 3 Million USD | 3.85% |
| 1995 Q2 | 3.3 Million USD | 11.11% |
| 1995 FY | - USD | 17.31% |
| 1995 Q4 | 3.6 Million USD | 3.23% |
| 1995 Q3 | 3.4 Million USD | 3.33% |
| 1994 Q1 | 2.7 Million USD | 108.33% |
| 1994 FY | - USD | 26.83% |
| 1994 Q4 | 2.9 Million USD | -3.7% |
| 1994 Q3 | 2.9 Million USD | 3.85% |
| 1994 Q2 | 2.8 Million USD | 4.0% |
| 1993 Q3 | 2.7 Million USD | -14.81% |
| 1993 Q4 | 1.8 Million USD | -47.83% |
| 1993 Q1 | 2.5 Million USD | -4.76% |
| 1993 FY | - USD | -10.87% |
| 1993 Q2 | 2.9 Million USD | 35.0% |
| 1992 FY | - USD | 12.2% |
| 1992 Q3 | 3.1 Million USD | 38.1% |
| 1992 Q1 | 2.2 Million USD | -12.5% |
| 1992 Q4 | 2.6 Million USD | -27.59% |
| 1992 Q2 | 2.4 Million USD | 0.0% |
| 1991 Q2 | 1.9 Million USD | 12.5% |
| 1991 FY | - USD | 43.86% |
| 1991 Q4 | 2.5 Million USD | 4.35% |
| 1991 Q3 | 2.4 Million USD | 27.78% |
| 1991 Q1 | 1.7 Million USD | 0.0% |
| 1990 Q3 | 1.9 Million USD | 0.0% |
| 1990 Q2 | 1.7 Million USD | 45.45% |
| 1990 Q1 | 1.2 Million USD | -31.25% |
| 1990 Q4 | 1.9 Million USD | 0.0% |
| 1990 FY | - USD | 39.02% |
| 1989 Q4 | 1.6 Million USD | 33.33% |
| 1989 Q2 | 800 Thousand USD | -81.58% |
| 1989 Q1 | 3.8 Million USD | 154.29% |
| 1989 Q3 | 1.3 Million USD | 71.43% |
| 1989 FY | - USD | 70.83% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 154.359% |
| AngioDynamics, Inc. | -14.29 Million USD | 273.559% |
| AtriCure, Inc. | -8.1 Million USD | 405.895% |
| Avinger, Inc. | -16.34 Million USD | 251.75% |
| Azenta, Inc. | 55.15 Million USD | 55.023% |
| BioLife Solutions, Inc. | -45.23 Million USD | 154.832% |
| The Cooper Companies, Inc. | 882.8 Million USD | 97.19% |
| Daxor Corporation | 329.74 Thousand USD | -7422.594% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 287.945% |
| Femasys Inc. | -13.16 Million USD | 288.353% |
| GlucoTrack, Inc. | -7.09 Million USD | 449.81% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -161.298% |
| Hologic, Inc. | 1.29 Billion USD | 98.086% |
| ICU Medical, Inc. | 307.69 Million USD | 91.938% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 98.964% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 363.895% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 49.367% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 477.255% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 477.255% |
| Masimo Corporation | 236.7 Million USD | 89.52% |
| Microbot Medical Inc. | -10.63 Million USD | 333.261% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -57.287% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 89.282% |
| Nephros, Inc. | -1.37 Million USD | 1898.767% |
| NovoCure Limited | -175.86 Million USD | 114.105% |
| NEXGEL, Inc. | -2.73 Million USD | 1008.608% |
| NEXGEL, Inc. | -2.73 Million USD | 1008.608% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 128.678% |
| OraSure Technologies, Inc. | 76.15 Million USD | 67.43% |
| Pro-Dex, Inc. | 8.33 Million USD | -197.672% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 158.548% |
| Predictive Oncology Inc. | -13.18 Million USD | 288.173% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 1087.479% |
| QuidelOrtho Corporation | 545.6 Million USD | 95.454% |
| Repligen Corporation | 124.29 Million USD | 80.043% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 8680.165% |
| STAAR Surgical Company | 33.22 Million USD | 25.333% |
| Sharps Technology, Inc. | -8.98 Million USD | 376.213% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 89.308% |
| Jin Medical International Ltd. | 3.44 Million USD | -620.471% |